T1	Participants 72 81	migraine.
T2	Participants 168 257	patients receiving topiramate (TPM) 100 mg/d in two divided doses for migraine prevention
T3	Participants 333 373	similar protocols and study populations.
T4	Participants 1144 1197	intent-to-treat (ITT) and study-completer populations
T5	Participants 2465 2493	migraine headache in adults.
